Suchergebnisse - "Magro, F"

PubPharm (4)

1

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients : Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study

enthalten in: Journal of Crohn's & colitis | 2019

von Magro, F. | Lopes, S. | Silva, M. | +18

2

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease : Results from the Multicenter European TEDDY Study

enthalten in: The American journal of gastroenterology | 2018

von Chaparro, M. | Verreth, A. | Lobaton, T. | +61

CommentIn: Am J Gastroenterol. 2018 Dec;113(12):1903. - PMID 29895982

3

Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort

enthalten in: Journal of Crohn's & colitis | 2015

von Vegh, Z. | Burisch, J. | Pedersen, N. | +84

ErratumIn: J Crohns Colitis. 2015 Oct;9(10):939. - PMID 26417056

4

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study

enthalten in: Journal of Crohn's & colitis | 2014

von Burisch, J. | Weimers, P. | Pedersen, N. | +51

1
[1]